Recently, a diet enriched in oleate and moderately restricted in hexacosanoate (C26:0) was found effective to reduce the plasma very long chain fatty acid (VLCFA) levels in patients with adrenoleukodys trophy (ALD), an X-linked disorder characterized by demyelination of the adrenal cortex and cerebral white matter, and accumulation of saturated VLCFA, particularly 026:0, in tissues of the demyelination. The infor mation about the C26:0 content in Japanese food was, however, almost nil except for one report about foods in the USA, but this did not include some Japanese common foods. With the hope of treating an ALD patient in our hospital, 026:0 contents in Japanese common foods (42 items) were measured. In our case, a one-hour direct transesterification method was used to obtain methylesters of total fatty acids in foods and they were applied directly to a selected ion monitoring gas chromatography-mass spectrometry for the quantitative C26:0 analysis. The C26:0 content in nuts and seeds as well as in fats and oils was found to be significantly higher than in other foods; the content was highest in peanuts. The content in almost all kinds of examined fishes, the common protein foods in Japan, was relatively low. From these data and that in the national nutrition survey in 1986, the daily intake of C26:0 from the average Japanese diet could be estimated to be 12-36mg. It can be recommended, therefore, that nuts and seeds as well as fats and oils should be restricted as severely as possible from the diet of ALD patients in Japan in order to keep daily C26:0 intake below 10mg as recommended in the USA.
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trophy, oleate, transesterification, selected ion monitoring gas chroma tography-mass spectrometry, nuts and seeds, fats and oils, fishes Adrenoleukodystrophy (ALD) is an X-linked disorder characterized by de myelination of cerebral white matter and adrenal cortex as well as accumulation of saturated very long chain fatty acids (VLCFAs) composed of around 26 carbons in tissues of the demyelination. The pathogenesis of VLCFA accumulation in ALD is, however, not sufficiently elucidated; some reports (1, 2) attributed it to endogenous factors, especially a decrease in enzyme activity of the VLCFA-oxidation system, while another (3) demonstrated an exogenous C26:0 incorporation into the patient's brain. Regarding the treatment for this disease, Van Duyn and his colleagues (4) tried at first restricting VLCFA intake in the patients but found that it did not normalize the plasma levels of C26:0. Next, Rizzo et al. (5) and Moser et al. (6) achieved significant reductions in plasma VLCFA levels of the patients with diets enriched in oleate (C18:1) along with a restriction in C26:0. Recently we received one ALD patient in our hospital and we wanted to restrict the C26:0 content in his diet; however, information about C26:0 content in Japanese common foods was almost nil unless we refer to the report of Van Duyn group (4) about foods in the USA but this did not include some Japanese common foods, especially fishes. We thus measured the C26:0 contents in Japanese common foods, with the hope of treating ALD patients in Japan including ours. 
METHODS

RESULTS
The C26:0 contents (mg/100g food) in foods examined by procedures as described above are shown in Table 3 . The data of Van Duyn group (4) on the food items which were the same as ours are also presented in that table. Among the examined foods, peanuts have the highest content (much higher than any others), and many kinds of fats and oils, cheese, potato chips, milk chocolate, ice cream, and bread have relatively high contents. Fishes have generally low contents. Comparing our data with that of Van Duyn group (4), C26:0 contents in about half of the food items (sunflower oil, mayonnaise, yogurt, etc.) are similar whereas in the other items (safflower oil, lard, cabbage, tofu, etc.) they differ.
DISCUSSION
Before our present work, Van Duyn group (4) reported the C26:0 contents in 135 American food items. However, their study did not include some Japanese common foods, especially several kinds of fishes. Accordingly, C26:0 contents in Japanese common foods were measured. The method used for preparing methyles ters of total fatty acids from food is a very convenient one from the viewpoints of both precision and time-saving. The SIM-GC-MS for quantitative analysis of C26:0 in the methylesters of total fatty acids is also a well-known procedure as the most rapid, accurate, and sensitive method. As shown in Table 3 , some of our data do not coincide well with those of Van Duyn group (4). The reason for the discrepancy is not clear at present, because many experimental conditions, for example, measuring method, food-producing place, food-processing, etc., differed. It is conceivable that contents of some elements in foods might vary depending on the place produced, especially if the distance were considerable.
From data presented here and the national nutrition survey in 1986 (8), the daily intake of C26:0 from the average Japanese diet could be estimated to be 12 36mg, which is close to that from American diet (15-40mg intake). Moser's group (6) achieved significant reduction in plasma VLCFA levels of 25 out of 36 ALD patients with a daily diet enriched in C18:1 (45-90ml of glyceryl trioleate oil containing about 90% of C18:1) along with a restriction in C26:0 below 10mg for about a hundred days. Presumably C18:1 competed with saturated fatty acids for their microsomal chain elongation system. Now, we can recommend that, beside the oleate-enrichment as described above, nuts and seeds as well as fats and oils should be restricted as severely as possible from the diet of ALD patients in Japan also, in order to keep daily C26:0 intake below 10mg as recommended by Moser's group (6) . We hope our present data will prove beneficial in the treatment of ALD as well as other VLCFA-accumulating disorders in Japan and other countries which consume food items similar to the ones in our study.
